Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex32i_pathfinder.htm |
| EX-23.1 - CONSENT - Pathfinder Cell Therapy, Inc. | f10k2014ex23i_pathfinder.htm |
| EX-31.1 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex31i_pathfinder.htm |
| EX-31.2 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex31ii_pathfinder.htm |
| EX-10.19 - FORM OF PROMISSORY NOTE - Pathfinder Cell Therapy, Inc. | f10k2014ex10xix_pathfinder.htm |
| EX-10.20A - COMPENSATION ARRANGEMENT WITH JOHN BENSON - Pathfinder Cell Therapy, Inc. | f10k2014ex10xxa_pathfinder.htm |
| EX-10.12(B) - EXTENSION NO. 3 TO RESEARCH AGREEMENT - Pathfinder Cell Therapy, Inc. | f10k2014ex10xiib_pathfinder.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Pathfinder Cell Therapy, Inc. | Financial_Report.xls |
| EX-32.2 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex32ii_pathfinder.htm |
| 10-K - ANNUAL REPORT - Pathfinder Cell Therapy, Inc. | f10k2014_pathfinder.htm |
Exhibit 10.5(a)
Compensation Arrangement Dr. Richard Franklin
Effective March 1, 2015, the annual compensation to which Dr. Richard Franklin is entitled under his consulting agreement with Pathfinder Cell Therapy, Inc. has been reduced to $60,000.